Skye Bioscience
(NASDAQ) SKYE
Skye Bioscience Financials at a Glance
Market Cap
$24.37M
Revenue (TTM)
$0.00
Net Income (TTM)
-$57.33M
EPS (TTM)
-$1.45
P/E Ratio
-0.48
Dividend
$0.00
Beta (Volatility)
0.67 (Low)
Dividend
$0.00
Beta (Volatility)
0.67 (Low)
Price
$0.70
Volume
61,527
Open
$0.69
Price
$0.70
Volume
61,527
Open
$0.69
Previous Close
$0.68
Daily Range
$0.68 - $0.71
52-Week Range
$0.57 - $4.99
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
0.67 (Low)
Price
$0.70
Volume
61,527
Open
$0.69
Previous Close
$0.68
Daily Range
$0.68 - $0.71
52-Week Range
$0.57 - $4.99
Estimated Earnings Date
Aug 6, 2026
SKYE News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Skye Bioscience
Industry
Biotechnology
Sector
Health CareEmployees
12
CEO
Punit S. Dhillon
Website
skyebioscience.comHeadquarters
San Diego, CA 92130, US
SKYE Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-217.27%
Return on Capital
-286.55%
Return on Assets
-295.27%
Earnings Yield
-2.08%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$24.37M
Shares Outstanding
35.14M
Volume
61.53K
Avg. Volume
190.95K
Financials (TTM)
Gross Profit
-$172.89K
Operating Income
-$59.08M
EBITDA
-$56.61M
Operating Cash Flow
-$42.43M
Capital Expenditure
-$14.00
Free Cash Flow
-$42.43M
Cash & ST Invst.
$17.11M
Total Debt
$311.32K
Skye Bioscience Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$172.89K
N/A
Gross Margin
0.00%
N/A
Market Cap
$24.37M
N/A
Market Cap/Employee
$2.03M
N/A
Employees
12
N/A
Net Income
-$12.51M
-12.7%
EBITDA
-$12.33M
-12.9%
Quarterly Fundamentals
Total Cash
$17.11M
-71.1%
Total Debt
$311.32K
-24.5%
Accounts Receivable
$9.53K
+49.1%
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$311.32K
+65.0%
Return on Assets
-2.95%
N/A
Return on Invested Capital
-6.56%
N/A
Free Cash Flow
-$8.56M
+99.9%
Operating Cash Flow
-$8.56M
+99.9%